Mesenchymal stromal cells implantation in combination with platelet lysate product is safe for reconstruction of human long bone nonunion

Narges, Labibzadeh; Mohsen, Emadedin; Roghayeh, Fazeli; Fatemeh, Mohseni; Seyedeh Esmat, Hosseini; Reza, Moghadasali; Soura, Mardpour; Vajiheh, Azimian; Maede Ghorbani, Liastani; Ali Mirazimi, Bafghi; Mohamadreza Baghaban, Eslaminejad; Nasser, Aghdami

Narges, Labibzadeh; Mohsen, Emadedin; Roghayeh, Fazeli; Fatemeh, Mohseni; Seyedeh Esmat, Hosseini; Reza, Moghadasali; Soura, Mardpour; Vajiheh, Azimian; Maede Ghorbani, Liastani; Ali Mirazimi, Bafghi; Mohamadreza Baghaban, Eslaminejad; Nasser, Aghdami.

Cell Journal [Yakhteh]. 2016; 18 (3): 302-309

em Inglês | IMEMR | ID: emr-183764

ABSTRACT

ABSTRACT

Objective:

nonunion is defined as a minimum of 9 months since injury without any visible progressive signs of healing for 3 months. Recent literature has shown that the application of mesenchymal stromal cells is safe, in vitro and in vivo, for treating long bone nonunion. The present study was performed to investigate the safety of mesenchymal stromal cell [MSC] implantation in combination with platelet lysate [PL] product for treating human long bone nonunion

Buscar no Google

Imprimir

XML

Índice: IMEMR (Mediterrâneo Oriental) Tipo de estudo: Ensaio Clínico Controlado Idioma: Inglês Revista: Cell J. [Yakhteh] Ano de publicação: 2016

Similares

MEDLINE

LILACS

LIS

Buscar no Google

Imprimir

XML

Índice: IMEMR (Mediterrâneo Oriental) Tipo de estudo: Ensaio Clínico Controlado Idioma: Inglês Revista: Cell J. [Yakhteh] Ano de publicação: 2016